Coherus BioSciences (CHRS) Earnings Date, Estimates & Call Transcripts → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free CHRS Stock Alerts $1.82 -0.06 (-3.19%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 7EstimatedActual EPS (May. 9) -$0.38 Missed By -$0.33 Consensus EPS (May. 9) -$0.05 Read Call TranscriptListen to Call Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCHRS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CHRS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Coherus BioSciences Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($1.14) EPSNext Year EPS Consensus Estimate: ($0.25) EPSCHRS Earnings Date and InformationCoherus BioSciences last released its quarterly earnings data on May 9th, 2024. The biotechnology company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.33. The company had revenue of $77.06 million for the quarter, compared to the consensus estimate of $102 million. Coherus BioSciences has generated ($0.78) earnings per share over the last year (($0.78) diluted earnings per share). Earnings for Coherus BioSciences are expected to grow in the coming year, from ($1.14) to ($0.25) per share. Coherus BioSciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.Read More Coherus BioSciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/7/2024(Estimated)------- 5/9/2024Q1 2024($0.05)($0.38)($0.33)($1.59)$102.00 million$77.06 million 3/13/2024Q4 2023($0.33)($0.72)($0.39)($0.73)$105.30 million$91.52 million11/6/2023Q3 2023($0.45)($0.38)+$0.07($0.35)$80.13 million$74.57 million8/2/2023Q2 2023($0.66)($0.49)+$0.17($0.49)$50.83 million$58.72 million5/8/2023Q1 2023($0.77)($0.89)($0.12)($0.82)$50.73 million$32.44 million3/6/2023Q4 2022($0.64)($0.76)($0.12)($0.76)$45.72 million$45.35 million Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________.11/8/2022Q3 2022($0.79)($1.11)($0.32)($1.11)$57.23 million$45.42 million8/4/2022Q2 2022($0.96)($0.65)+$0.31($0.65)$58.00 million$60.15 million 5/5/2022Q1 2022($0.80)($1.24)($0.44)($1.24)$68.07 million$60.12 million2/17/2022Q4 2021($0.61)($0.60)+$0.01($0.60)$83.32 million$73.37 million 11/7/2021Q3 2021($0.22)($0.34)($0.12)($0.49)$86.96 million$82.50 million 8/5/2021Q2 2021($0.25)($0.40)($0.15)($0.40)$82.65 million$87.64 million 5/6/2021Q1 2021$0.09($2.37)($2.46)($2.37)$97.87 million$83.03 million 2/23/2021Q4 2020$0.25$0.12($0.13)$0.12$114.90 million$110.42 million 11/5/2020Q3 2020$0.34$0.33($0.01)$0.33$120.50 million$113.55 million 8/6/2020Q2 2020$0.26$0.70+$0.44$0.70$100.33 million$135.67 million 5/7/2020Q1 2020$0.44$0.54+$0.10$0.60$116.25 million$116.18 million 2/27/2020Q4 2019$0.68$0.56($0.12)$0.53$123.60 million$123.86 million 11/6/2019Q3$0.36$0.63+$0.27$0.63$93.58 million$111.68 million 8/1/2019Q2 2019($0.08)$0.32+$0.40$0.32$81.05 million$83.43 million Coherus BioSciences Earnings - Frequently Asked Questions When is Coherus BioSciences's earnings date? Coherus BioSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on CHRS's earnings history. Did Coherus BioSciences beat their earnings estimates last quarter? In the previous quarter, Coherus BioSciences (NASDAQ:CHRS) missed the analysts' consensus estimate of ($0.05) by $0.33 with a reported earnings per share (EPS) of ($0.38). Learn more on analysts' earnings estimate vs. CHRS's actual earnings. How can I listen to Coherus BioSciences's earnings conference call? The conference call for Coherus BioSciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Coherus BioSciences's conference call transcript? The conference call transcript for Coherus BioSciences's latest earnings report can be read online. Read Transcript How much revenue does Coherus BioSciences generate each year? Coherus BioSciences (NASDAQ:CHRS) has a recorded annual revenue of $257.24 million. How much profit does Coherus BioSciences generate each year? Coherus BioSciences (NASDAQ:CHRS) has a recorded net income of -$237.89 million. CHRS has generated -$0.78 earnings per share over the last four quarters. What is Coherus BioSciences's EPS forecast for next year? Coherus BioSciences's earnings are expected to grow from ($1.14) per share to ($0.25) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CGEN Earnings HUMA Earnings SRRK Earnings PRME Earnings CRGX Earnings PROK Earnings RGNX Earnings HLVX Earnings ITOS Earnings TSHA Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (NASDAQ:CHRS) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWho are Nvidia’s New Silent Partners?Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin Analytics41 banks launch ‘crypto dollar’Stansberry ResearchGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist My Default Watchlist Adding Coherus BioSciences, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.